In the orthopedic setting, the anesthesiologist often encounters the r
heumatoid patient after the disease has run a resistant course. Despit
e optimal medical therapy, the patient at this point has intolerable l
evels of pain or limitation of function because of structural joint da
mage. Given the duration of the disease and severity of symptoms, a nu
mber of pharmacologic modalities already have been tried for which the
patient has suffered some side effects. Now that the disease has span
ned a significant period, the patient has become older with one or mor
e coexisting indications, and clinical results. Improvements in prosth
etic design and surgical technique have resulted in more predictable r
esults for total elbow replacement.